These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29428226)

  • 1. Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: A systematic review and meta-analysis.
    Vardakas KZ; Mavroudis AD; Georgiou M; Falagas ME
    J Infect; 2018 Apr; 76(4):321-327. PubMed ID: 29428226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
    Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
    Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis.
    Vardakas KZ; Mavroudis AD; Georgiou M; Falagas ME
    Int J Antimicrob Agents; 2018 Apr; 51(4):535-547. PubMed ID: 29288723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
    Gu WJ; Wang F; Tang L; Bakker J; Liu JC
    Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria.
    Choe J; Sohn YM; Jeong SH; Park HJ; Na SJ; Huh K; Suh GY; Jeon K
    Ther Adv Respir Dis; 2019; 13():1753466619885529. PubMed ID: 31680646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study.
    Almangour TA; Alruwaili A; Almutairi R; Alrasheed A; Alhifany AA; Eljaaly K; Alkofide H; Alhammad AM; Ghonem L; Alsharidi A
    Int J Infect Dis; 2021 Jul; 108():406-412. PubMed ID: 34111542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant Gram-negative infections: the use of colistin.
    Michalopoulos AS; Karatza DC
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children.
    Polat M; Kara SS; Tapısız A; Tezer H; Kalkan G; Dolgun A
    Paediatr Drugs; 2015 Aug; 17(4):323-30. PubMed ID: 25939411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.
    Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G
    Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis.
    Vardakas KZ; Falagas ME
    Int J Antimicrob Agents; 2017 Feb; 49(2):233-238. PubMed ID: 27686609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin-based Treatment of Multidrug-resistant Gram-negative Bacterial Pulmonary Infections After Lung Transplantation.
    Carillo C; Pecoraro Y; Anile M; Poggi C; Oliva A; Amore D; Bruschini P; Naldi G; Mantovani S; Francioni F; Pugliese F; De Giacomo T; Venuta F; Diso D
    Transplant Proc; 2019; 51(1):202-205. PubMed ID: 30661895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates.
    Hussain K; Salat MS; Ambreen G; Mughal A; Idrees S; Sohail M; Iqbal J
    Expert Opin Drug Saf; 2020 Dec; 19(12):1641-1649. PubMed ID: 32892635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of colistin in adult patients: A cross-sectional study.
    Giacobbe DR; Saffioti C; Losito AR; Rinaldi M; Aurilio C; Bolla C; Boni S; Borgia G; Carannante N; Cassola G; Ceccarelli G; Corcione S; Dalla Gasperina D; De Rosa FG; Dentone C; Di Bella S; Di Lauria N; Feasi M; Fiore M; Fossati S; Franceschini E; Gori A; Granata G; Grignolo S; Grossi PA; Guadagnino G; Lagi F; Maraolo AE; Marinò V; Mazzitelli M; Mularoni A; Oliva A; Pace MC; Parisini A; Patti F; Petrosillo N; Pota V; Raffaelli F; Rossi M; Santoro A; Tascini C; Torti C; Trecarichi EM; Venditti M; Viale P; Signori A; Bassetti M; Del Bono V; Giannella M; Mikulska M; Tumbarello M; Viscoli C;
    J Glob Antimicrob Resist; 2020 Mar; 20():43-49. PubMed ID: 31207379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis.
    Karageorgos SA; Bassiri H; Siakallis G; Miligkos M; Tsioutis C
    J Antimicrob Chemother; 2019 Sep; 74(9):2497-2506. PubMed ID: 31049586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
    Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
    Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.